US Earnings Financial Results SEC Filings — September 14, 2026

14-09-2026

Reborn Coffee, Inc. reported total net revenues of approximately $11.5M for the six months ended June 30, 2026, a significant increase from $3.5M in the prior-year period, primarily driven by new service income from a related party of $8.0M (none in prior year). However, the company's net loss attributable to shareholders worsened to $4.4M from $3.5M previously, and cash and cash equivalents fell sharply by 88% to $0.3M at June 30, 2026 from $2.6M at December 31, 2025, raising liquidity concerns.

• · Operating loss improved to $2.4M in H1 2026 from $6.1M in H1 2025.
• · Professional fees decreased to $0.7M in H1 2026 from $1.3M in H1 2025.
• · Interest expense dropped 92% in H1 2026 to $64,768 from $850,710.
• · Wholesale and online revenue surged 503% to $234,985 in H1 2026 from $38,951.
• · Amortization of debt discount was $854,113 in H1 2026 (none in prior period).
• · Loss on debt extinguishment was $618,942 in H1 2026 (up from $200,333).
• · Derivative liability nearly doubled to $1.1M from $503,384.
• · Convertible debt balance was $3.0M (net of discount) at June 30, 2026.
• · Total liabilities exceeded total assets by $0.7M, resulting in a stockholders' equity of only $0.7M.
• · The company had a loan receivable from a related party of $3.8M and a loan payable to related parties of $1.3M.
• · Non-controlling interest in subsidiary increased to $369K from $134K.
• · Cash used in operating activities improved to $1.7M outflow from $3.2M outflow.
• · Accumulated deficit grew to $35.1M from $30.7M at year-end 2025.
• · Weighted average shares outstanding increased to 8.1M from 4.7M (H1 comparison).

14-09-2026

United Natural Foods Inc (UNFI) reported a financial turnaround in fiscal year 2026, posting net income of $84 million compared to a net loss of $118 million in FY2025. The improvement was driven by a $31 million swing to operating income of $211 million and a 27% increase in Adjusted EBITDA to $701 million. However, total net sales declined 2.0% to $31,152 million, with weakness in the Conventional segment (-11.5%) and Retail segment (-7.9%) partially offset by 7.0% growth in Natural segment sales.

• · Net cash provided by operating activities was $540 million in FY2026, up from $470 million in FY2025.
• · Cash and cash equivalents declined to $37 million at August 1, 2026 from $44 million at August 2, 2025.
• · The company has $1,237 million variable-rate debt maturing largely in 2031, with a weighted-average interest rate of 5.8%.
• · Total liabilities decreased 9.2% from $6,041 million to $5,487 million, while total stockholders' equity increased 4.4% from $1,554 million to $1,622 million.
• · Goodwill remained unchanged at $19 million, while intangible assets net decreased 11.7% from $576 million to $509 million.
• · The company's LIFO charge reversed to $19 million in FY2026 from a benefit of ($2) million in FY2025.
• · Interest expense, net, declined 13.7% from $146 million to $126 million.

14-09-2026

Coda Octopus Group reported revenue growth of 9.2% to $7.72M for the third quarter of fiscal 2026 (three months ended July 31, 2026), up from $7.06M in the same period last year. Net income for the quarter rose 8.3% to $1.39M ($0.12 per diluted share) from $1.28M ($0.11 per diluted share). However, cash flow from operations declined 20.4% to $3.43M for the nine-month period, and the company recorded a foreign currency translation loss of $98,810 in Q3 versus a gain of $70,492 a year ago, reflecting mixed performance.

• · Inventory decreased slightly to $13.49M from $13.64M (down 1.1% from Oct 31, 2025).
• · Accounts receivable increased to $5.62M from $3.73M (up 50.6% from Oct 31, 2025), contributing to the decline in operating cash flow.
• · Goodwill remained unchanged at $3.64M.
• · Intangible assets, net decreased to $2.85M from $3.18M (down 10.5% from Oct 31, 2025) due to amortization.
• · Deferred revenue (current) increased to $1.83M from $1.72M (up 6.2% from Oct 31, 2025).
• · Accounts payable decreased to $0.98M from $1.41M (down 30.6% from Oct 31, 2025).
• · Accumulated other comprehensive loss improved to -$1.31M from -$1.88M (improvement of 30.4% from Oct 31, 2025).
• · Cash paid for taxes increased sharply to $1.13M from $0.42M in the prior year nine-month period (up 172.8%).
• · Provision for contingent consideration liability (PAL Earn-out) increased to $438,588 from $158,872 (up 176.1% YoY for nine months).
• · Stock-based compensation decreased to $39,063 from $196,156 (down 80.1% YoY for nine months).

14-09-2026

Value Line Inc reported net income of $4.655M for Q1 FY27 (July 31, 2026), down 28% from $6.460M in the prior-year quarter, driven by declines in publishing revenues and lower income from its EAM Trust investment. Total publishing revenues fell 6.4% to $8.051M, while revenues and profits interests from the EAM Trust dropped 24.3% to $3.879M. The company maintained a strong balance sheet with $109.166M in shareholders' equity and no debt, though cash and cash equivalents decreased sharply to $16.016M from $24.180M at the end of April 2026.

• · Cash and cash equivalents fell 33.8% to $16.016M from $24.180M at April 30, 2026, primarily due to $9.484M used in investing activities (mainly purchases of equity securities).
• · The company repurchased 2,920 treasury shares for $100,000 during the quarter.
• · Dividends declared totaled $3.284M, consistent with the $3.285M dividends payable at quarter end.
• · Total expenses decreased only 1.2% to $7.024M, with advertising and promotion costs increasing 14.5% to $821,000.
• · Unearned revenue (a key indicator of subscription renewals) decreased slightly to $20.911M from $21.039M at April 30, 2026.
• · The EAM Trust investment value declined to $59.979M from $60.217M at April 30, 2026.
• · Equity securities holdings increased 38.9% to $35.564M from $25.603M at April 30, 2026, reflecting significant new purchases.
• · Net cash provided by operating activities fell 15.4% to $4.705M from $5.560M in the prior-year quarter.

14-09-2026

Hain Celestial reported a 13.2% decline in net sales to $1,353,429 thousand for fiscal 2026, with a net loss before income taxes of $306,780 thousand, though this loss narrowed by 40.3% from the prior year. The North America segment saw a 22.9% sales decline, while International sales fell only 0.4%, and organic net sales declined 0.2% overall. Goodwill impairment charges decreased significantly to $193,219 thousand from $428,882 thousand, but the company still recorded substantial impairments and a net cash increase of only $3,723 thousand.

• · Organic net sales decline was 0.2% in fiscal 2026, compared to a 4.3% decline in fiscal 2025, indicating improvement.
• · International segment organic net sales declined only 0.4%, while North America declined 22.9%.
• · Goodwill impairment in the U.K. reporting unit was $42,293 thousand during the three months ended June 30, 2026, reducing U.K. goodwill to zero.
• · Purchases of property, plant and equipment decreased to $20,613 thousand in fiscal 2026 from $25,284 thousand in fiscal 2025.
• · Interest and other financing expense increased 11.1% to $56,957 thousand, while other expense, net surged to $46,342 thousand from $875 thousand.
• · Amortization of acquired intangible assets increased 66.8% to $10,802 thousand.

14-09-2026

Ocean Power Technologies reported total revenue of $1.7M for the quarter ended July 31, 2026, up 44% from $1.2M in the prior-year period, driven by a surge in lease revenue ($0.7M vs $0.1M) and strong growth in the Americas ($1.4M vs $0.1M). However, the company's net loss widened to $10.5M from $7.4M, and gross margin turned deeply negative at ($2.8M) compared to ($23K) a year ago, reflecting a sharp increase in cost of revenues to $4.5M. Cash and cash equivalents fell to $7.4M from $8.7M at the start of the quarter, and shareholders' equity declined to $8.5M from $12.5M.

• · Inventory increased 43% to $4.6M from $3.2M at April 30, 2026.
• · Accounts receivable more than doubled to $1.2M from $0.6M.
• · Accounts payable surged 54% to $6.7M from $4.4M.
• · Contract liabilities (deferred revenue) decreased 16% to $5.1M from $6.0M.
• · Operating cash outflow worsened to ($10.2M) from ($5.6M) in the prior year.
• · The company recorded a $4.9M non-cash gain from change in fair value of derivative (warrant liability).
• · Net cash used in investing activities improved to ($0.1M) from ($1.5M) due to lower capex.
• · Basic and diluted net loss per share was ($1.28) in both Q2 FY26 and Q2 FY25.

14-09-2026

HeartSciences Inc. filed its 10-Q for the quarter ended July 31, 2026, reporting a net loss of $3.17M, widening 54% from a $2.05M loss in the same quarter last year. Revenue was essentially flat at $2,100 (up from $1,900), while operating expenses surged 57% to $2.94M, driven by a 132% increase in selling, general and administrative costs. The company's cash position deteriorated sharply, falling from $1.66M at April 30, 2026 to just $29,906 at July 31, 2026, and total stockholders' equity swung from a positive $226,060 to a deficit of $2.03M.

• · Inventory reserve for obsolescence increased 294% from $85,575 to $337,455 during the quarter.
• · Capitalized software increased 38% to $989,689, reflecting continued investment despite cash constraints.
• · Accounts payable surged 221% to $1.02M, indicating potential strain on supplier relationships.
• · Stock-based compensation expense jumped 323% YoY to $738,889, a significant non-cash cost.
• · The company issued 425,000 restricted shares to management during the quarter.
• · Net cash used in operating activities improved 32% to $1.32M from $1.95M in the prior year quarter.

14-09-2026

WEWARDS, INC. filed its 10-K for the fiscal year ended May 31, 2026, reporting no revenue and a net loss of $497,512, an improvement from the $596,140 net loss in the prior year. The company's cash balance fell to $0 from $693,290, and total assets dropped to just $300. However, the company received a significant debt forgiveness of $14,349,866 from a related party (Sky Rover), which was credited to additional paid-in capital, improving stockholders' equity from a deficit of $13,852,454 to a deficit of only $100.

• · General and administrative expenses decreased significantly from $21,945 to $2,733.
• · Professional fees increased from $68,425 to $73,735.
• · Interest expense, related party decreased from $525,000 to $437,260.
• · The company had no current or long-term liabilities as of May 31, 2026, compared to $14,546,231 in total liabilities as of May 31, 2025.
• · The company's accumulated deficit increased from $19,121,469 to $19,618,981.
• · The company's independent registered public accounting firm is M&K CPAS, PLLC (PCAOB ID: 2738).

14-09-2026

Dave & Buster's Entertainment reported a net loss of $12.5M for Q2 FY26 (three months ended August 4, 2026), compared to net income of $11.4M in the prior-year quarter. Total revenues declined 2.4% to $544.1M, driven by a 8.7% drop in entertainment revenue to $332.6M, partially offset by a 9.6% increase in food and beverage revenue to $211.5M. Operating income fell sharply from $53.0M to $19.4M, and the company reported a net loss per diluted share of $(0.36) versus EPS of $0.32 a year ago.

• · Total debt decreased 8.1% to $1,318.5M as of Aug 4, 2026 from $1,434.3M as of Feb 3, 2026.
• · Operating cash flow for the six months improved 23.7% to $160.6M from $129.8M in the prior year.
• · Capital expenditures for the six months fell 22.1% to $190.0M from $243.8M.
• · The company had $16.0M in cash and cash equivalents at quarter end, up from $12.0M a year ago.
• · Anti-dilutive awards excluded from diluted EPS rose to 4.10M shares in Q2 FY26 from 0.68M in Q2 FY25.
• · Deferred entertainment revenue decreased to $69.5M from $73.8M at fiscal year start.
• · Deferred gift card revenue fell to $14.4M from $19.3M at fiscal year start.
• · No share repurchases occurred in the six months ended Aug 4, 2026, compared to $23.9M in the prior year period.

14-09-2026

Helio Corp reported a net loss of $1,471,490 for Q3 FY2026 (three months ended July 31, 2026), widening from a $950,754 loss in the prior-year quarter. Revenue declined 24.7% to $590,626 from $784,587, driven by drops in service fees, engineering fees, and materials revenue. However, gross profit improved significantly to $265,092 from $98,390, and the company raised $2.45M in financing activities, ending the period with $520,504 in cash versus $7,305 at the start of the fiscal year.

• · Shareholders' deficit improved to ($2,424,177) from ($4,060,138) at October 31, 2025, driven by issuance of preferred stock and conversion of debt.
• · Derivative liability surged to $1,655,559 from $39,543, reflecting new derivative instruments issued with convertible notes.
• · Accumulated deficit deepened to ($11,836,076) from ($4,972,507) at October 31, 2025.
• · Operating expenses for the nine months ended July 31, 2026 totaled $4,715,947, up from $3,374,396 in the prior-year period, driven by higher general and administrative expenses ($3,359,080 vs $2,072,456).
• · Non-cash items significantly impacted net loss: loss on debt extinguishment of $1,236,303, amortization of debt discount of $864,738, and change in fair value of derivative liability of $731,919.
• · The company issued 1,130,000 shares of Series A, B, and C Convertible Preferred Stock during the nine months, raising net proceeds of $1,053,500.
• · Common stock issued for services totaled $2,481,918 (non-cash) for the nine months ended July 31, 2026, compared to $0 in the prior period.
• · Cash used in operating activities increased to $1,937,196 from $1,549,753 in the prior-year period.

14-09-2026

Wealthfront Corp reported total revenue of $91.9M for Q2 FY26 (ending July 31, 2026), up slightly 0.8% from $91.1M in Q2 FY25, and $182.4M for the six-month period, up 3.8% from $175.6M. However, net income fell sharply: Q2 net income was $17.8M (down 48.9% from $34.7M), and the six-month net income was $30.6M (down 49.6% from $60.7M). The decline was primarily driven by a 60.1% surge in product development costs and a 76.7% increase in general & administrative expenses, alongside an 870.4% jump in stock-based compensation for the six-month period.

• · Basic EPS for Q2 FY26 was $0.12, down from $0.86 in Q2 FY25 (86% decline) — a far steeper drop than net income due to share dilution; weighted-average basic shares outstanding more than tripled from 40.5M to 150.1M.
• · Diluted EPS for Q2 FY26 was $0.10, down from $0.24 in Q2 FY25 (58.3% decline).
• · Stock-based compensation expense for six months ended July 31, 2026 was $33.5M, up 870.4% from $3.5M in the prior year period.
• · Cash management revenue — the largest revenue segment — declined 10.3% YoY in Q2, from $68.9M to $61.8M.
• · Investment advisory revenue grew strongly in Q2 (+30.7% YoY) to $28.8M, partially offsetting the cash management decline.
• · The company repurchased 3.3M shares of common stock during Q2 FY26 for $31.8M, and 8.0M shares total (cost $73.2M) over the six-month period.
• · Client-held fractional shares (an asset) nearly doubled from $514.9M (Jan 2026) to $816.9M (July 2026), reflecting strong client engagement and platform activity.
• · Due from clients increased 33.1% (to $302.6M) and payable to clearing broker increased 33.1% (to $302.7M) — both largely offsetting.
• · Cash and cash equivalents increased to $453.3M from $440.8M at Jan 2026, despite heavy share repurchase activity.
• · The company had no redeemable convertible preferred stock outstanding (fully converted).

14-09-2026

Uranium Royalty Corp. reported a strong quarter with net income attributable to shareholders of $16,247 thousand for the three months ended July 31, 2026, up from $1,025 thousand in the prior-year period, driven by a 110% increase in uranium inventory sales revenue to $50,967 thousand. The company completed the Sweetwater Acquisition, adding significant mineral properties and land, funded by $611,713 thousand in common shares, $22,602 thousand in preferred shares, and $535,661 thousand in long-term debt. However, cash and restricted cash declined sharply to $103,651 thousand from $282,037 thousand at April 30, 2026, and the company recorded a foreign currency translation loss of $9,630 thousand, contributing to a comprehensive income of only $6,621 thousand.

• · Total assets increased to $1,911,677 thousand at July 31, 2026 from $373,320 thousand at April 30, 2026, primarily due to the Sweetwater acquisition.
• · The company incurred $15,061 thousand in costs related to the Sweetwater Acquisition during the quarter.
• · A gain of $12,784 thousand was recognized on the subscription receipts liability.
• · Interest income increased to $2,479 thousand from $66 thousand in the prior-year quarter.
• · The company recorded a foreign currency translation loss of $9,630 thousand, leading to comprehensive income of only $6,621 thousand.
• · Cash used in investing activities was $265,532 thousand, primarily for the Sweetwater acquisition.
• · The company drew $40,000 thousand on its credit facility during the quarter.
• · Weighted average basic shares outstanding increased to 156,987,539 from 133,636,271 year-over-year.

14-09-2026

The Children's Place reported a net loss of $30,951 thousand for the thirteen weeks ended August 1, 2026, compared to a net loss of $5,365 thousand in the prior-year quarter, reflecting a significant deterioration. For the twenty-six weeks ended August 1, 2026, the net loss widened to $84,142 thousand from $39,388 thousand in the prior-year period, driven by higher operating losses and increased interest expenses. Total stockholders' deficit deepened to $138,972 thousand as of August 1, 2026, from $54,183 thousand at January 31, 2026, while total assets increased to $742,307 thousand.

• · Operating loss for the thirteen weeks ended August 1, 2026 was $13,037 thousand, compared to operating income of $4,106 thousand in the prior-year quarter.
• · Operating loss for the twenty-six weeks ended August 1, 2026 was $55,217 thousand, compared to an operating loss of $20,011 thousand in the prior-year period.
• · Selling, general, and administrative expenses increased slightly to $90,061 thousand for the thirteen weeks ended August 1, 2026 from $89,596 thousand in the prior-year quarter.
• · Depreciation and amortization decreased to $6,254 thousand for the thirteen weeks ended August 1, 2026 from $7,570 thousand in the prior-year quarter.
• · Related party interest expense increased to $2,099 thousand for the thirteen weeks ended August 1, 2026 from $1,868 thousand in the prior-year quarter.
• · Other interest expense increased significantly to $16,193 thousand for the thirteen weeks ended August 1, 2026 from $6,167 thousand in the prior-year quarter.
• · Total comprehensive loss for the thirteen weeks ended August 1, 2026 was $31,683 thousand, compared to $6,875 thousand in the prior-year quarter.
• · Accumulated deficit increased to $365,089 thousand as of August 1, 2026 from $280,947 thousand at January 31, 2026.
• · Short-term debt of $17,833 thousand was recorded as of August 1, 2026, with no comparable balance at January 31, 2026.
• · The company issued 9,231 thousand shares through a rights offering during the twenty-six weeks ended August 2, 2025, raising $90,000 thousand.

14-09-2026

For the three months ended July 31, 2026, Marwynn Holdings reported revenue of $1.09M, a dramatic increase from $41,250 in the prior-year period, driven by new revenue from food & beverage sales ($450,000) and e-waste materials sales ($570,445). However, the company continued to post a net loss from continuing operations of $108,927 (improved from a $2.64M loss a year ago), and cash & cash equivalents fell sharply to just $3,541 from $152,250 at April 30, 2026, reflecting persistent cash burn.

• · Cash burn persisted: net cash used in operating activities was $327,612 in Q2 FY26 vs $95,149 in Q2 FY25.
• · The company took on a new loan of $200,000 and repaid $50,000, resulting in a net $150,000 from financing activities.
• · Accounts receivable surged to $1.31M from $764,562 at April 30, 2026, indicating a large build in receivables.
• · The food & beverage segment posted a tiny net loss of $693, while consulting services lost $115,373. The sale of e-waste materials segment generated a net income of $7,139.
• · Total liabilities increased 41.3% to $604,953, driven by new accounts payable of $42,176 and a loan payable of $150,000.

14-09-2026

Conexeu Sciences Inc. reported a net loss of $7.7M for the three months ended July 31, 2026, compared to a $1.3M loss in the same period last year, and a net loss of $11.7M for the nine-month period versus $2.0M in the prior year. Operating expenses surged to $7.7M (from $1.3M) in Q3 and $11.8M (from $2.1M) year-to-date, driven by large increases in consulting, business development, and management salaries. The company raised $2.9M in net private placement proceeds and $2.7M from a warrant inducement program, but cash and cash equivalents fell from $4.8M to $2.0M, and shareholders' equity decreased from $7.4M to $5.9M.

• · Net loss per share (basic and diluted) was $(0.29) for Q3 FY26 vs $(0.09) in Q3 FY25, and $(0.52) year-to-date vs $(0.19) in prior year.
• · Consulting expenses were the largest operating cost at $3.8M in Q3 (vs $0.5M) and $5.4M year-to-date (vs $0.7M).
• · Business development expenses rose to $1.2M in Q3 (from $52k) and $1.4M year-to-date (from $146k).
• · Management and directors' salaries and fees (related parties) were $1.5M in Q3 (vs $0.5M) and $2.8M year-to-date (vs $0.8M).
• · Prepaid expenses increased sharply to $4.5M from $0.5M at year-end.
• · Accounts payable and accrued liabilities rose to $0.8M from $0.3M.
• · The company issued 5.5M shares under the warrant inducement program and 1.75M shares upon exercise of warrants.
• · Stock-based compensation expense was $1.5M year-to-date, compared to $0 in the prior year period.
• · Interest income was $34k in Q3 (vs $386) and $130k year-to-date (vs $386).
• · No revenue was reported; the company is in a pre-revenue stage.

14-09-2026

Frequency Electronics reported a strong quarter for the period ended July 31, 2026, with revenues surging 69.8% to $23.5M from $13.8M in the prior-year quarter, driven by a significant increase in gross margin to $10.8M (45.8% of revenue) from $5.1M (36.8%). Net income rose dramatically to $4.2M ($0.41 per share) from $0.6M ($0.07 per share), and the company completed a public offering that raised $58.8M in net proceeds, boosting cash and equivalents to $62.7M. However, cash flow from operations was impacted by a $4.1M net change in operating assets and liabilities, and the company incurred $0.6M in public offering issuance costs.

• · The company completed a public offering, issuing 1,086,957 shares of common stock, raising $58.8M in net proceeds.
• · Cash and cash equivalents surged to $62.7M from $2.9M at the end of the prior quarter, largely due to the public offering.
• · Operating cash flow was $2.6M, up from $1.2M in the prior year, but was impacted by a $4.1M net cash outflow from changes in operating assets and liabilities.
• · The company made a $0.1M cash acquisition of an equity method investment and incurred a $0.4M non-cash liability for another equity method investment.
• · Total inventories decreased slightly to $22.2M from $22.6M, driven by a decline in work-in-progress.
• · Contract assets increased to $19.6M from $17.3M, while contract liabilities increased to $11.5M from $9.4M.
• · Total lease liabilities decreased to $7.0M from $7.7M.
• · The company had no shares to exclude from the calculation of dilutive securities for either period.

14-09-2026

Minerva Gold Inc. filed its 10-Q for the quarter ended May 31, 2026, reporting a net loss of $2,221, a slight improvement from the $2,275 loss in the same quarter last year. However, revenue declined 25% to $9,000 from $12,000, and the company ended the period with zero cash and cash equivalents, down from $7,077 at the prior quarter-end. Total assets fell 76% to $2,450, while the accumulated deficit widened to $(88,785).

• · General and administrative expenses decreased to $11,221 from $14,275 YoY, a 21.4% reduction.
• · Net cash used in operating activities improved to $(6,132) from $(7,600) YoY.
• · Cash used in financing activities was $(945) (net repayment of shareholder loan) vs. $0 in the prior year.
• · Deferred revenue fell to $0 from $4,500 at the prior quarter-end, indicating all previously deferred revenue was recognized.
• · The company had no cash paid for interest or taxes in either period.
• · Loans from related parties decreased slightly to $54,835 from $55,780.
• · Stockholders' deficit worsened to $(52,385) from $(50,164) at February 28, 2026.

14-09-2026

YIJIA GROUP CORP. reported a net loss of $123,101 for the three months ended July 31, 2026, compared to a net loss of $46,301 in the same period last year, as revenue surged 209% to $321,576 driven by new healthy food product sales of $234,576. However, gross profit declined 56% to $30,521 due to a sharp increase in cost of revenue to $291,055, and operating expenses rose 51% to $152,683, resulting in a significantly wider operating loss of $122,162. Cash flow from operations dropped to $6,965 from $263,811 a year earlier, and total assets decreased 8% to $2,239,335.

• · Accounts receivable decreased 56% to $316,871 from $726,743, while inventories increased 185% to $301,294.
• · Accounts payable fell 41% to $122,805 from $208,813.
• · Retained earnings dropped 15% to $707,296 from $830,397.
• · The company had no debt or interest expense.
• · Healthy food products segment generated $234,576 in revenue with a gross profit of only $6,701 (2.9% margin), while dietary supplement segment had $87,000 revenue and $23,820 gross profit (27.4% margin).
• · Both segments reported operating losses: healthy food products lost $93,066 and dietary supplement lost $29,096.

14-09-2026

Radiant Logistics, Inc. reported its annual results for the fiscal year ended June 30, 2026. Total revenues increased 3.5% to $934.4M and net income attributable to the company rose 8.6% to $18.8M. However, the adjusted gross profit margin slipped from 26.5% to 26.3% and operating cash flow improved significantly to $17.5M, while the company increased share repurchases and completed the acquisition of Weport.

• · Revenue growth was driven by Transportation (+3.3% to $882.8M) and Value-added services (+6.8% to $51.6M).
• · U.S. transportation adjusted gross profit margin declined from 25.0% to 24.5% and Canada transportation margin slid from 22.2% to 21.7%.
• · Operating partner commissions as a % of adjusted gross profit increased to 33.5% from 32.8%.
• · Selling, general and administrative expenses as a % of adjusted gross profit decreased to 17.2% from 17.7%.
• · Accounts receivable increased $27.9M to $162.8M, driving a $24.3M working capital cash outflow.
• · Goodwill increased to $122.4M from $117.6M, reflecting the Weport acquisition.
• · The company repurchased $3.5M of common stock in FY 2026 vs. $0.8M in FY 2025.
• · Net cash provided by operating activities improved to $17.5M from $13.3M.
• · Interest expense rose to $2.3M from $1.3M due to higher debt levels.
• · The company recognized a $6.2M gain from the change in fair value of contingent consideration.

14-09-2026

Kestra Medical Technologies reported Q1 FY26 revenue of $30.97M, up 59.9% YoY from $19.37M, driven by strong commercial execution. Gross profit more than doubled to $17.50M from $8.85M, with gross margin expanding to 56.5% from 45.7%. However, the net loss widened to $44.09M from $25.83M, driven by a $6.30M loss on debt extinguishment and a 43.4% increase in SG&A expenses to $48.36M. Cash burn remained elevated with operating cash outflow of $32.30M, and total cash and investments declined to $244.7M from $262.2M at April 30, 2026.

• · Gross margin improved to 56.5% in Q1 FY26 from 45.7% in Q1 FY25.
• · Operating cash outflow was $32.30M in Q1 FY26 vs $26.27M in Q1 FY25.
• · Net cash used in investing activities was $21.35M, including $8.34M in property and equipment purchases and $13.02M in marketable securities purchases.
• · Financing activities provided $22.50M, primarily from $75.00M in new long-term debt proceeds, partially offset by $46.40M in debt repayment and $3.76M early termination fee.
• · Accumulated deficit grew to $695.95M as of July 31, 2026 from $651.86M at April 30, 2026.
• · Warrant liabilities were reduced to $0 from $1.37M at April 30, 2026.
• · Medical rental equipment (net) increased to $89.31M from $83.05M at April 30, 2026.

14-09-2026

Pharma-Bio Serv, Inc. reported mixed results for the third quarter and first nine months of fiscal 2026. Revenue grew 19.0% YoY to $2.34M in Q3 and 7.0% to $7.33M in the nine-month period, driven by improved gross margins. However, the company remained unprofitable on an operating basis, posting a Q3 operating loss of $71,812, though this was a significant improvement from a $313,877 loss a year ago. Net income for the nine-month period was $251,627, a turnaround from a $100,361 net loss in the prior-year period, but cash and cash equivalents fell sharply by 55.1% to $1.52M from $3.38M at fiscal year-end, largely due to a $1.72M dividend payment.

• · Cash used in operating activities was $694,558 in 9M FY26, compared to $494,552 used in 9M FY25.
• · Cash used in financing activities was $1,720,017 in 9M FY26, primarily due to $1,717,627 in cash dividends paid.
• · The company's current ratio (current assets / current liabilities) improved to 11.3x as of July 31, 2026, from 7.7x at October 31, 2025.
• · Total liabilities decreased 42.8% to $994,740 from $1,738,799 at fiscal year-end, driven by a $653,642 reduction in current tax liabilities.
• · The company had no operating lease liabilities as of July 31, 2026, down from $28,834 at October 31, 2025.
• · Basic and diluted earnings per share for 9M FY26 was $0.011, compared to a loss of ($0.004) in the prior-year period.

14-09-2026

Laredo Oil, Inc. filed its 10-K annual report for the year ending May 31, 2026, reporting a net loss of approximately $7.97M, significantly wider than the $3.18M loss in the prior year. Revenue declined 67% to $3.14K, while operating expenses surged to $7.05M, largely driven by a 169% increase in general, selling, and administrative expenses. The company's total liabilities exceeded total assets, resulting in a stockholders' deficit of $12.93M, worsening from the prior year deficit of $12.57M.

• · Net cash used in operating activities from continuing operations was $3.13M in FY2026, up from $1.41M in FY2025
• · Net cash provided by financing activities was $3.30M in FY2026, compared to $2.38M in FY2025
• · As of May 31, 2026, current liabilities of $13.22M exceeded current assets of $492K
• · Stock-based compensation expense of $2.29M was recognized in FY2026, none in FY2025
• · Gain on sale of membership interest in Hell Creek Crude, LLC of $272,892 was recorded in FY2026

14-09-2026

Somitos Corp. filed its 10-Q for the quarter ended August 31, 2026, reporting its first-ever revenue of $7,695, a significant improvement from zero revenue in the prior-year period. However, the company continued to incur a net loss of $12,054, though this narrowed from a net loss of $19,070 in Q3 2025. Cash and cash equivalents declined to $43,718 from $45,167, and the accumulated deficit deepened to $(90,962) from $(78,908), reflecting ongoing operating losses.

• · The company's net loss per share (basic and diluted) was $(0.00) for both the current and prior-year quarters.
• · No income tax expense or benefit was recorded for either period due to a full valuation allowance against deferred tax assets.
• · Deferred tax assets related to net operating losses were $2,531 for the three months ended August 31, 2026, fully offset by a valuation allowance.
• · The company's total liabilities exceeded total assets, resulting in a stockholders' deficit of $43,462 as of August 31, 2026, compared to $31,408 as of May 31, 2026.
• · No financing activities occurred in the current quarter, whereas $15,000 was raised in the prior-year quarter through related party loans and stock issuance.
• · The company remains an 'emerging growth company' as defined under the JOBS Act, with criteria thresholds noted for revenue ($1.07 billion), IPO anniversary, non-convertible debt issuance, and public float ($700 million).

14-09-2026

Star Gold Corp. reported a net loss of $991,838 for the three months ended July 31, 2026, a significant increase from a net loss of $130,384 in the same period last year. Total operating expenses surged to $999,404 from $114,650, driven by a sharp rise in pre-development expense ($469,683 vs. $13,989) and management/administrative costs ($353,421 vs. $27,429). The company raised $782,849 through warrant exercises, boosting cash to $1,965,745, but its accumulated deficit widened to $14,931,613.

• · Cash used in operating activities was $636,313 in Q2 FY26 vs. $56,407 in Q2 FY25.
• · Cash used in investing activities was $112,000 in Q2 FY26 vs. $12,000 in Q2 FY25, including $100,000 for a reclamation bond.
• · The company had no revenue and no provision for income taxes in either period.
• · Total assets increased to $2,997,455 as of July 31, 2026 from $2,851,738 as of April 30, 2026.
• · Total liabilities increased to $417,382 from $124,352 over the same period.
• · Stockholders' equity decreased to $2,580,073 from $2,727,386 due to the net loss.
• · Weighted average shares outstanding increased to 196,205,897 from 97,290,810 year-over-year.
• · Basic and diluted loss per share was $(0.01) for Q2 FY26 vs. $Nil for Q2 FY25.

14-09-2026

George Risk Industries reported net sales of $6,850,000 for the quarter ended July 31, 2026, up 16.1% from $5,898,000 in the prior-year quarter, with gross profit rising 6.7% to $3,227,000. However, net income declined sharply by 42.2% to $2,192,000 from $3,792,000, primarily due to a significant drop in unrealized gains on equity securities (from $2,381,000 to $802,000) and higher income tax expense. Total assets increased to $74,178,000 from $71,372,000, while stockholders' equity rose to $65,383,000 from $63,355,000.

• · Basic EPS fell to $0.45 from $0.78 YoY, a 42.3% decline.
• · Diluted EPS fell to $0.45 from $0.77 YoY.
• · Operating expenses increased 8.7% YoY to $1,321,000 from $1,215,000.
• · Income from operations increased 5.4% YoY to $1,906,000 from $1,808,000.
• · Other income decreased 50.2% YoY to $1,453,000 from $2,915,000, driven by lower unrealized gains.
• · Accounts receivable (trade) decreased to $4,683,000 from $5,025,000, while inventories increased to $13,056,000 from $11,822,000.
• · Cash and cash equivalents increased to $6,842,000 from $5,156,000.
• · Accumulated other comprehensive income swung to a loss of $(176,000) from $(25,000).
• · Company repurchased 700 shares of common stock during the quarter for $13,000.
• · Dividends payable remained at $3,726,000.

14-09-2026

Benitec Biopharma Inc. filed its annual 10-K for the fiscal year ended June 30, 2026, reporting a net loss of $45.5M, widening from a $37.9M loss in FY2025. Operating expenses increased 22.6% to $51.2M, driven by higher R&D and G&A costs, while cash and cash equivalents nearly doubled to $180.0M following a $98.2M net stock offering. The company's accumulated deficit deepened to $273.7M, and net cash used in operations improved to $16.5M from $23.6M in the prior year.

• · The company's net loss per share improved to ($0.98) from ($1.05) in FY2025, despite a larger net loss, due to a 28.6% increase in weighted average shares outstanding.
• · Total liabilities increased to $5.6M from $2.3M, driven by higher trade payables and accrued employee benefits.
• · The company reported a foreign currency transaction gain of $120K in FY2026 versus a loss of $71K in FY2025.
• · No gain on extinguishment of liabilities was recorded in FY2026, compared to a $764K gain in FY2025.
• · The company's cash runway appears extended with $180.0M in cash and cash equivalents, up from $97.7M, following a $98.2M net stock offering.
• · Share-based compensation expense rose 51.6% to $26.4M, representing a significant portion of operating expenses.

14-09-2026

R F Industries Ltd reported strong growth for the three and nine months ended July 31, 2026, with net sales up 21.1% YoY in the quarter and 9.9% YoY in the nine-month period. Consolidated net income swung from a loss of $98K in the prior nine-month period to a profit of $2,271K, while diluted EPS improved from $(0.01) to $0.20. However, cash flow from operations declined 37% YoY, and cash and cash equivalents fell 17.9% sequentially, reflecting higher financing outflows.

• · Aerospace customer concentration declined: 16% of net sales for the nine months ended July 31, 2026 vs 22% in the prior year period.
• · Net cash used in financing activities increased to $1,812K for the nine months ended July 31, 2026 from $162K in the prior year period, driven by line of credit payments of $2,118K.
• · Income taxes paid increased to $901K for the nine months ended July 31, 2026 from $169K in the prior year period.
• · Tax withholding related to vesting of restricted stock totaled $142K for the nine months ended July 31, 2026.
• · Cash and cash equivalents decreased by $625K during the nine months ended July 31, 2026, compared to an increase of $2,161K in the prior year period.

14-09-2026

Immersion Corp reported a net loss of $4.6M for Q3 FY26, a significant improvement from a $13.7M loss in Q3 FY25. The company swung to a net income attributable to Immersion stockholders of $4.9M, compared to a $0.9M loss in the prior year, driven by higher interest income and lower operating losses. However, total revenues were nearly flat at $294.4M, up only 0.8% YoY, and the company's core royalty and license revenue declined 1.8% to $3.8M.

• · Immersion's selling and administrative expenses decreased 5.3% YoY to $3.5M.
• · Barnes & Noble Education's product and other revenue grew slightly to $276.9M from $274.2M.
• · Barnes & Noble Education's long-term borrowings increased significantly to $123.5M from $71.0M.
• · The company paid $2.5M in dividends to Immersion stockholders in Q3 FY26, compared to none in Q3 FY25.
• · Net cash used in operating activities improved to -$43.6M from -$61.7M.
• · Basic and diluted EPS attributable to Immersion stockholders was $0.17, compared to -$0.03 in the prior year.

14-09-2026

Verde Resources, Inc. filed its 10-K annual report for fiscal year 2026, highlighting key milestones including a $2 million strategic investment from Ergon, first commercial purchase orders generating approximately $460,000 in revenue, and a supply agreement with Biochar Solutions LLC. The company is pursuing an asset-light licensing model with Ergon for its biochar-asphalt technology, but has not yet funded a required $3 million loan and license fee to C-Twelve, creating a risk of breach. While the company has made progress in commercialization, it has not generated significant revenue and faces risks related to scaling production, market adoption, and capital needs.

• · The company has not yet funded a $2 million loan and $1 million license fee to C-Twelve required by end of July 2026, creating a risk of breach.
• · The company has only 23 total employees and independent consultants, with just 1 in sales and marketing.
• · The company's go-forward commercialization strategy shifted away from Verde V24 to supplying engineered biochar for use with Ergon's asphalt liquids.
• · Minimal business-related capital outlays are anticipated over the next twelve months as Ergon's existing infrastructure will support production and distribution.
• · The company attended the GenZero Climate Summit 2026 in Singapore to expand its presence in Southeast Asia.

14-09-2026

American Battery Technology Company (ABAT) filed its 10-K annual report for the fiscal year ended June 30, 2026, reporting a 407% surge in annual revenue to $21.7 million from $4.3 million in FY2025. Q4 FY2026 revenue also grew sharply to $8.2 million from $2.8 million in the prior-year quarter, and the company swung to a gross profit of $1.3 million from a gross loss of $2.6 million. However, the filing highlights significant risks including a recently-issued federal directive that may prevent the export of black mass to foreign customers, material weaknesses in internal controls over financial reporting, heavy customer concentration, and dependence on volatile metal prices and government grants.

• · The company has identified material weaknesses in its internal controls over financial reporting (ICFR).
• · A recently-issued federal directive may prevent the company from exporting black mass to foreign customers, which would materially adversely affect revenue.
• · A small number of customers account for a substantial majority of revenue, presenting concentration risk.
• · Operations are concentrated at a single recycling facility and a single exploration-stage project in Nevada.
• · The company does not currently intend to pay dividends on its common shares.
• · Cash cost of goods sold (non-GAAP) for Q4 FY2026 was $6.0 million, compared to $4.1 million in Q4 FY2025.

14-09-2026

Bakhu Holdings, Corp. (BKUH) filed its quarterly report (10-Q) for the period ended October 31, 2024, showing zero net revenue and a net loss of $771,387 for the quarter, an improvement from a $1,131,478 net loss in the same prior-year period. Total assets remain minimal at $14,035, while total liabilities increased to $11,307,989 from $11,037,011. The company has a substantial accumulated deficit of $51,682,544 and negative stockholders' equity of $11,293,954, highlighting continued financial distress with no operating revenue.

• · Zero net revenue for both Q1 FY25 and Q1 FY24.
• · Stock-based compensation included in consulting fees: $488,983 (Q1 FY25) vs $626,975 (Q1 FY24).
• · Interest expense increased to $107,947 from $64,111 YoY, a 68% rise.
• · Current portion of notes payable – related parties remains $150,000; non-current related-party notes payable increased slightly to $7,537,627 from $7,515,355.
• · No options or warrants were granted, exercised, forfeited, or expired during the quarter.
• · No income tax provision recorded in either period.

14-09-2026

Venyra Corp reported its first-ever quarterly revenue of $17,700 for the three months ended July 31, 2026, compared to zero revenue in the same period last year, marking a significant milestone. However, the company continues to operate at a net loss of $4,221, though this is a substantial improvement from the $12,077 net loss in the prior-year period. Total assets increased to $87,367 from $80,038, while stockholders' equity declined to $4,064 from $8,285 due to the accumulated deficit.

• · The company had no revenue in the prior-year period, making the $17,700 revenue a first-time achievement.
• · Operating expenses increased 81.5% to $12,182, driven by higher general and administrative costs.
• · Cash burn improved significantly: net cash used in operations was only $282 versus $14,361 in the prior year.
• · The company has $56,002 in loans from related parties, unchanged from April 30, 2026.
• · Intangible assets (website and API development) total $61,751, with estimated future amortization of $11,213 in FY2027 and $14,952 annually from FY2028 through FY2030.
• · Stockholders' equity dropped 51% from $8,285 to $4,064 due to the accumulated deficit increasing to $45,338.
• · No investing or financing activities occurred in Q2 FY27, compared to $21,960 in intangible asset development and $36,757 in related party loan proceeds in Q2 FY26.

14-09-2026

Starlink AI Acquisition Corp (OTAI) filed its 10-Q for the quarter ended July 31, 2026, reporting net income of $707,825 for the three-month period and $674,969 for the six-month period. The company completed its IPO during the period, raising $105 million from public units and $2.26 million from private units, with total assets growing from $332,134 to $107 million. However, the company continues to report operating losses ($140,167 for Q3 and $173,023 for the six months) and has an accumulated deficit of $3.1 million, reflecting the typical pre-business combination expense profile of a SPAC.

• · The company completed its IPO during the period, issuing 10,500,000 units at $10.00 per unit, with a partial exercise of the underwriters' over-allotment option for 500,000 units.
• · Founder shares were retroactively restated to reflect issuance of an additional 1,150,000 shares to the Sponsor on February 20, 2026.
• · 250,000 Founder Shares were forfeited upon expiration of the unexercised portion of the over-allotment option in June 2026.
• · The company has a deferred underwriting fee payable of $3,675,000 as of July 31, 2026.
• · Net cash used in operating activities was $215,504 for the six months ended July 31, 2026.
• · The company had a promissory note – related party of $300,000 as of January 31, 2026, which was fully repaid during the period.

14-09-2026

For the six months ended June 30, 2026, BPGC Acquisition Corp. reported a net income of $7,888,538, a significant turnaround from a net loss of $6,426,231 in the same period of 2025. This improvement was driven by a $8,117,623 gain from the change in fair value of derivative warrant liabilities, though general and administrative expenses declined sharply to $248,253 from $1,171,426. However, the company experienced redemptions of Class A ordinary shares, with cash held in trust decreasing to $1,342,175 from $1,868,462 at year-end 2025, and cash balances remain at zero.

• · Class A ordinary shares subject to possible redemption decreased to 110,419 shares as of June 30, 2026 from 155,614 shares as of December 31, 2025, reflecting 45,195 shares redeemed.
• · Series C Preference shares of 430,000 were issued during the period (previously zero), with a par value of $0.0001.
• · Total shareholders' deficit improved to $(11,610,403) from $(19,479,773) as of December 31, 2025.
• · Due to related party increased to $528,632 from $279,173 as of December 31, 2025.
• · Net cash used in operating activities was $249,459 for the six months ended June 30, 2026, compared to $0 in the prior year period.

14-09-2026

Glidelogic Corp. reported its first-ever revenue of $160,038 for the three and six months ended July 31, 2026, generating a gross profit of $59,538 and net income of $35,194 for the quarter, a significant turnaround from a net loss of $23,030 in the prior-year quarter. However, the company's accumulated deficit widened to $189,279, and cash flow from operations remained negative at $(1,325) for the six-month period, while total liabilities of $131,687 far exceeded total assets of $13,757, leaving stockholders' equity deeply negative at $(117,930).

• · Total liabilities of $131,687 exceed total assets of $13,757, resulting in a stockholders' deficit of $117,930.
• · Accumulated deficit increased from $197,261 at January 31, 2026 to $189,279 at July 31, 2026, reflecting net income for the period.
• · Cash and cash equivalents rose from $68 at January 31, 2026 to $149 at July 31, 2026, despite negative operating cash flow.
• · The company has a gross deferred tax asset of $32,003 from NOL carryforwards, but no net deferred tax asset is recognized.
• · General and administrative expenses increased from $23,030 in Q2 FY2026 to $24,344 in Q2 FY2027, and from $37,997 to $51,556 for the six-month periods.
• · No income tax provision was recorded for any period presented.

14-09-2026

Rapid Line Inc. (RPDL) filed its 10-Q for the quarter ended July 31, 2026, reporting no revenue and a net loss of $42,900 for the three-month period, widening from a net loss of $28,197 in the prior-year quarter. However, for the six-month period ended July 31, 2026, the net loss was $92,199, compared to a net income of $70,086 in the same period of 2025, which was driven by $114,731 in other income/debt forgiveness. The company's cash position declined significantly, with cash and equivalents falling to $8,692 from $19,081 at the start of the fiscal year, while total liabilities increased to $189,596 from $111,886. The company has no revenue and continues to rely on financing activities.

• · The company's accumulated deficit grew to $328,028 as of July 31, 2026, up from $235,830 at January 31, 2026.
• · Total stockholders' equity was negative $160,698 as of July 31, 2026, compared to negative $68,500 at January 31, 2026.
• · General and administrative expenses for the three months ended July 31, 2026 were $42,900, up from $28,197 in the prior-year period.
• · The company reported a deferred tax asset net operating loss carryover of $68,886, fully offset by a valuation allowance.
• · Accounts payable/accrued liabilities decreased to $1,347 from $2,694 at January 31, 2026.
• · Due to third party (long-term) increased to $188,249 from $109,192 at January 31, 2026.

14-09-2026

Kaival Brands reported a net loss of $244,407 for the three months ended July 31, 2026, compared to a net loss of $20,662 in the prior quarter, with total revenues declining 61% YoY to $55,254. For the nine months, revenues fell 53% YoY to $185,722, while operating expenses dropped 77% to $1,640,221. The company's cash position deteriorated sharply, falling 75% from $534,406 to $133,221, and stockholders' equity turned negative at ($244,407), reflecting ongoing challenges including FDA marketing denial orders and reliance on Bidi Vapor.

• · Net cash used in operating activities for the nine months ended July 31, 2026 was $401,185, compared to $2,633,374 in the prior year period.
• · Accounts receivable increased from $120,000 to $135,254, while prepaid expenses decreased from $14,850 to $8,250.
• · Accrued expenses decreased from $170,000 to $105,000, while accounts payable increased from $349,289 to $382,132.
• · The company received $21,000 in equity securities as consideration on a note receivable, a non-cash transaction.
• · Weighted average common shares outstanding for the nine months ended July 31, 2026 were 14,070,627, up from 10,855,306 in the prior year period.
• · The company's accumulated deficit increased to ($55,532,314) as of July 31, 2026, from ($55,288,446) as of April 30, 2026.
• · The company faces an ITC complaint involving Bidi, itself, and 40 other respondents, and FDA marketing denial orders for BIDI® Stick products.

14-09-2026

PharmaCyte Biotech reported a net loss of $5.1M for the quarter ended July 31, 2026, an improvement from the $8.4M loss in the prior-year quarter, primarily due to lower fair-value losses on investments. However, total assets declined 21.5% to $36.7M from $46.8M at April 30, 2026, driven by a $5.6M drop in the QCLS investment and a $3.2M decrease in QCLS warrant assets. The company remains a pre-revenue clinical-stage biotech with no revenue and cash burn of $0.8M in operating activities, though cash reserves of $17.7M provide a runway.

• · General and administrative expenses increased 25.7% YoY to $946,708, while research and development costs decreased 36.9% YoY to $60,000.
• · The company recorded a $5.6M loss from change in fair value of QCLS investment and a $3.2M loss from change in fair value of QCLS warrant assets, partially offset by a $4.2M gain on warrant liabilities.
• · Accumulated deficit grew to $109.5M from $104.4M at April 30, 2026.
• · Series C preferred stock accretion of $621,217 and dividends of $83,399 were recorded in the quarter, impacting net loss attributable to common stockholders.
• · Stockholders' equity decreased 17.4% to $27.5M from $33.3M at April 30, 2026.
• · The company had no revenue and no income tax benefit or expense in either period.
• · All outstanding stock options (1,160,294) are exercisable as of July 31, 2026, with a weighted average exercise price of $2.13.

14-09-2026

ECO SCIENCE SOLUTIONS, INC. (ESSI) reported its quarterly results for the period ending July 31, 2026, showing first-time revenue generation of $1,952 for the quarter and $2,205 for the six-month period, compared to zero revenue in the prior-year periods. However, the company continued to incur significant net losses ($256,314 for Q2 and $499,091 for H1) and experienced a sharp decline in cash from $32,699 to $15,551. Total liabilities ($1,673,389) far exceed total assets ($105,334), resulting in a worsened stockholders' deficit of ($1,568,055).

• · Operating expenses for Q2 FY2026 were $247,766 vs $242,898 in Q2 FY2025, an increase of 2.0%.
• · Management and consulting fees remained the largest expense at $122,500 for Q2 FY2026 and $245,000 for H1 FY2026.
• · Cash used in operating activities improved to $17,148 in H1 FY2026 from $162,482 in H1 FY2025.
• · The company had no financing cash flows in H1 FY2026 versus $162,763 of related party loan advances in H1 FY2025.
• · Accounts payable and accrued expenses increased to $1,015,417 from $889,788 at year-start.
• · Related party payable of $300,530 arose during the period.
• · Accumulated deficit grew to ($69,783,144) from ($69,284,053) at January 31, 2026.
• · Basic and diluted net loss per share was ($0.01) for the quarter vs ($0.12) in the prior year quarter, reflecting a much higher share count (24,952,656 vs 2,118,303).